Strategies in cardiac tissue engineering

ANZ Journal of Surgery

Volumn 80, Issue 10, 2010, Pages 683-693

  Tee, Richard ^a   Lokmic, Zerina ^a,b   Morrison, Wayne A ^a,b,c   Dilley, Rodney J ^a,c,d  

^a O'Brien Institute   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

^d Australian Tissue Engineering Centre   (Australia)

Author keywords

Heart transplantation; Myocardium; Review; Stem cells; Tissue engineering

Indexed keywords

TISSUE SCAFFOLD;

ANIMAL; CYTOLOGY; HEART MUSCLE; HUMAN; METHODOLOGY; REVIEW; STEM CELL; TISSUE ENGINEERING;

ANIMALS; HUMANS; MYOCARDIUM; STEM CELLS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 78650508334     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2010.05435.x     Document Type: Review

References (106)

1. Boyle A. Current status of cardiac transplantation and mechanical circulatory support. Curr. Heart Fail. Rep. 2009; 6: 28-33.
2. Langer R, Vacanti JP. Tissue engineering. Science 1993; 260: 920-6.
3. Cao Y, Vacanti JP, Paige KT, Upton J, Vacanti CA. Transplantation of chondrocytes utilizing a polymer-cell construct to produce tissue-engineered cartilage in the shape of a human ear. Plast. Reconstr. Surg. 1997; 100: 297-302; discussion 3-4.
4. Rakusan K, Flanagan MF, Geva T, Southern J, Van Praagh R. Morphometry of human coronary capillaries during normal growth and the effect of age in left ventricular pressure-overload hypertrophy. Circulation 1992; 86: 38-46.
5. Korecky B, Hai CM, Rakusan K. Functional capillary density in normal and transplanted rat hearts. Can. J. Physiol. Pharmacol. 1982; 60: 23-32.
6. Vunjak-Novakovic G, Tandon N, Godier A et al. Challenges in cardiac tissue engineering. Tissue Eng. Part B Rev. 2009; 16: 169-87.
7. Zimmermann WH, Eschenhagen T. Cardiac tissue engineering for replacement therapy. Heart Fail. Rev. 2003; 8: 259-69.
8. Zimmermann WH, Cesnjevar R. Cardiac tissue engineering: implications for pediatric heart surgery. Pediatr. Cardiol. 2009; 30: 716-23.
9. Jawad H, Lyon AR, Harding SE, Ali NN, Boccaccini AR. Myocardial tissue engineering. Br. Med. Bull. 2008; 87: 31-47.
10. Eschenhagen T, Zimmermann WH. Engineering myocardial tissue. Circ. Res. 2005; 97: 1220-31.
11. Leor J, Aboulafia-Etzion S, Dar A et al. Bioengineered cardiac grafts: a new approach to repair the infarcted myocardium? Circulation 2000; 102: III56-61.
12. Li RK, Jia ZQ, Weisel RD, Mickle DA, Choi A, Yau TM. Survival and function of bioengineered cardiac grafts. Circulation 1999; 100: II63-9.
13. Lesman A, Habib M, Caspi O et al. Transplantation of a tissue-engineered human vascularized cardiac muscle. Tissue Eng. Part A. 2009; 16: 115-25.
14. Zimmermann WH, Melnychenko I, Wasmeier G et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat. Med. 2006; 12: 452-8.
15. Furuta A, Miyoshi S, Itabashi Y et al. Pulsatile cardiac tissue grafts using a novel three-dimensional cell sheet manipulation technique functionally integrates with the host heart, in vivo. Circ. Res. 2006; 98: 705-12.
16. Sekine H, Shimizu T, Hobo K et al. Endothelial cell coculture within tissue-engineered cardiomyocyte sheets enhances neovascularization and improves cardiac function of ischemic hearts. Circulation 2008; 118: S145-52.
17. Stevens KR, Kreutziger KL, Dupras SK et al. Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue. Proc. Natl. Acad. Sci. U S A 2009; 106: 16568-73.
18. Kelm JM, Djonov V, Hoerstrup SP et al. Tissue-transplant fusion and vascularization of myocardial microtissues and macrotissues implanted into chicken embryos and rats. Tissue Eng. 2006; 12: 2541-53.
19. Birla RK, Borschel GH, Dennis RG, Brown DL. Myocardial engineering in vivo: formation and characterization of contractile, vascularized three-dimensional cardiac tissue. Tissue Eng. 2005; 11: 803-13.
20. Morritt AN, Bortolotto SK, Dilley RJ et al. Cardiac tissue engineering in an in vivo vascularized chamber. Circulation 2007; 115: 353-60.
21. Ott HC, Matthiesen TS, Goh SK et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat. Med. 2008; 14: 213-21.
22. Segers VF, Lee RT. Stem-cell therapy for cardiac disease. Nature 2008; 451: 937-42.
23. Hjortnaes J, Bouten CV, Van Herwerden LA, Grundeman PF, Kluin J. Translating autologous heart valve tissue engineering from bench to bed. Tissue Eng. Part B Rev. 2009; 15: 307-17.
24. Sacks MS, Schoen FJ, Mayer JE. Bioengineering challenges for heart valve tissue engineering. Annu. Rev. Biomed. Eng. 2009; 11: 289-313.
25. Lokmic Z, Mitchell GM. Engineering the microcirculation. Tissue Eng. Part B Rev. 2008; 14: 87-103.
26. Zhang WJ, Liu W, Cui L, Cao Y. Tissue engineering of blood vessel. J. Cell. Mol. Med. 2007; 11: 945-57.
27. Dominici M, Le Blanc K, Mueller I et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315-7.
28. Orlic D, Kajstura J, Chimenti S et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001; 410: 701-5.
29. Reinecke H, Minami E, Zhu WZ, Laflamme MA. Cardiogenic differentiation and transdifferentiation of progenitor cells. Circ. Res. 2008; 103: 1058-71.
30. Tomita S, Li RK, Weisel RD et al. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 1999; 100: II247-56.
31. Fukuda K. Development of regenerative cardiomyocytes from mesenchymal stem cells for cardiovascular tissue engineering. Artif. Organs 2001; 25: 187-93.
32. Makino S, Fukuda K, Miyoshi S et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J. Clin. Invest. 1999; 103: 697-705.
33. Shiota M, Heike T, Haruyama M et al. Isolation and characterization of bone marrow-derived mesenchymal progenitor cells with myogenic and neuronal properties. Exp. Cell Res. 2007; 313: 1008-23.
34. Mangi AA, Noiseux N, Kong D et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat. Med. 2003; 9: 1195-201.
35. Planat-Benard V, Menard C, Andre M et al. Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ. Res. 2004; 94: 223-9.
36. Rangappa S, Fen C, Lee EH, Bongso A, Sim EK. Transformation of adult mesenchymal stem cells isolated from the fatty tissue into cardiomyocytes. Ann. Thorac. Surg. 2003; 75: 775-9.
37. Van Dijk A, Niessen HW, Zandieh Doulabi B, Visser FC, Van Milligen FJ. Differentiation of human adipose-derived stem cells towards cardiomyocytes is facilitated by laminin. Cell Tissue Res. 2008; 334: 457-67.
38. Choi YS, Dusting GJ, Stubbs S et al. Differentiation of human adipose-derived stem cells into beating cardiomyocytes. J. Cell. Mol. Med. 2010; 14: 878-89.
39. Choi YS, Matsuda K, Dusting GJ, Morrison WA, Dilley RJ. Engineering cardiac tissue in vivo from human adipose-derived stem cells. Biomaterials 2010; 31: 2236-42.
40. Kehat I, Khimovich L, Caspi O et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat. Biotechnol. 2004; 22: 1282-9.
41. Kehat I, Kenyagin-Karsenti D, Snir M et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J. Clin. Invest. 2001; 108: 407-14.
42. Mummery C, Ward D, Van Den Brink CE et al. Cardiomyocyte differentiation of mouse and human embryonic stem cells. J. Anat. 2002; 200: 233-42.
43. Yang L, Soonpaa MH, Adler ED et al. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 2008; 453: 524-8.
44. Caspi O, Lesman A, Basevitch Y et al. Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ. Res. 2007; 100: 263-72.
45. Nussbaum J, Minami E, Laflamme MA et al. Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J. 2007; 21: 1345-57.
46. Zwi L, Caspi O, Arbel G et al. Cardiomyocyte differentiation of human induced pluripotent stem cells. Circulation 2009; 120: 1513-23.
47. Zhang J, Wilson GF, Soerens AG et al. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ. Res. 2009; 104: e30-41.
48. Moretti A, Bellin M, Jung CB et al. Mouse and human induced pluripotent stem cells as a source for multipotent Isl1+ cardiovascular progenitors. FASEB J. 2010; 24: 700-11.
49. McDevitt TC, Woodhouse KA, Hauschka SD, Murry CE, Stayton PS. Spatially organized layers of cardiomyocytes on biodegradable polyurethane films for myocardial repair. J. Biomed. Mater. Res. A. 2003; 66: 586-95.
50. Pego AP, Van Luyn MJ, Brouwer LA et al. In vivo behavior of poly(1, 3-trimethylene carbonate) and copolymers of 1, 3-trimethylene carbonate with D, L-lactide or epsilon-caprolactone: degradation and tissue response. J. Biomed. Mater. Res. A. 2003; 67: 1044-54.
51. Ishii O, Shin M, Sueda T, Vacanti JP. In vitro tissue engineering of a cardiac graft using a degradable scaffold with an extracellular matrix-like topography. J Thorac. Cardiovasc. Surg. 2005; 130: 1358-63.
52. Ozawa T, Mickle DA, Weisel RD, Koyama N, Ozawa S, Li RK. Optimal biomaterial for creation of autologous cardiac grafts. Circulation 2002; 106: I176-82.
53. Amir G, Miller L, Shachar M et al. Evaluation of a peritoneal-generated cardiac patch in a rat model of heterotopic heart transplantation. Cell Transplant. 2009; 18: 275-82.
54. Schmidt CE, Baier JM. Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering. Biomaterials 2000; 21: 2215-31.
55. Kutschka I, Chen IY, Kofidis T et al. Collagen matrices enhance survival of transplanted cardiomyoblasts and contribute to functional improvement of ischemic rat hearts. Circulation 2006; 114: I167-73.
56. Zimmermann WH, Schneiderbanger K, Schubert P et al. Tissue engineering of a differentiated cardiac muscle construct. Circ. Res. 2002; 90: 223-30.
57. Shimizu T, Sekine H, Yang J et al. Polysurgery of cell sheet grafts overcomes diffusion limits to produce thick, vascularized myocardial tissues. FASEB J. 2006; 20: 708-10.
58. Radisic M, Park H, Gerecht S, Cannizzaro C, Langer R, Vunjak-Novakovic G. Biomimetic approach to cardiac tissue engineering. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2007; 362: 1357-68.
59. Dvir T, Kedem A, Ruvinov E et al. Prevascularization of cardiac patch on the omentum improves its therapeutic outcome. Proc. Natl. Acad. Sci. U S A 2009; 106: 14990-5.
60. Zimmermann WH, Fink C, Kralisch D, Remmers U, Weil J, Eschenhagen T. Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnol. Bioeng. 2000; 68: 106-14.
61. Zimmermann WH, Didie M, Wasmeier GH et al. Cardiac grafting of engineered heart tissue in syngenic rats. Circulation 2002; 106: I151-7.
62. Yildirim Y, Naito H, Didie M et al. Development of a biological ventricular assist device: preliminary data from a small animal model. Circulation 2007; 116: I16-23.
63. Zimmermann WH, Didie M, Doker S et al. Heart muscle engineering: an update on cardiac muscle replacement therapy. Cardiovasc. Res. 2006; 71: 419-29.
64. Naito H, Melnychenko I, Didie M et al. Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle. Circulation 2006; 114: I72-8.
65. Shimizu T, Yamato M, Kikuchi A, Okano T. Two-dimensional manipulation of cardiac myocyte sheets utilizing temperature-responsive culture dishes augments the pulsatile amplitude. Tissue Eng. 2001; 7: 141-51.
66. Shimizu T, Yamato M, Isoi Y et al. Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ. Res. 2002; 90: e40.
67. Kelm JM, Ehler E, Nielsen LK, Schlatter S, Perriard JC, Fussenegger M. Design of artificial myocardial microtissues. Tissue Eng. 2004; 10: 201-14.
68. Carmeliet P. Angiogenesis in life, disease and medicine. Nature 2005; 438: 932-6.
69. Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat. Rev. Mol. Cell Biol. 2007; 8: 221-33.
70. Lohela M, Bry M, Tammela T, Alitalo K. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr. Opin. Cell Biol. 2009; 21: 154-65.
71. Jakobsson L, Bentley K, Gerhardt H. VEGFRs and Notch: a dynamic collaboration in vascular patterning. Biochem. Soc. Trans. 2009; 37: 1233-6.
72. Gerhardt H, Betsholtz C. Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res. 2003; 314: 15-23.
73. Jain RK. Molecular regulation of vessel maturation. Nat. Med. 2003; 9: 685-93.
74. Asahara T, Murohara T, Sullivan A et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-7.
75. Shi Q, Rafii S, Wu MH et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998; 92: 362-7.
76. Risau W, Flamme I. Vasculogenesis. Annu. Rev. Cell Dev. Biol. 1995; 11: 73-91.
77. Colton CK. Implantable biohybrid artificial organs. Cell Transplant. 1995; 4: 415-36.
78. Suzuki R, Hattori F, Itabashi Y et al. Omentopexy enhances graft function in myocardial cell sheet transplantation. Biochem. Biophys. Res. Commun. 2009; 387: 353-9.
79. Lovett M, Lee K, Edwards A, Kaplan DL. Vascularization strategies for tissue engineering. Tissue Eng. Part B Rev. 2009; 15: 353-70.
80. Hirschi KK, Rohovsky SA, D'Amore PA. PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J. Cell Biol. 1998; 141: 805-14.
81. Darland DC, D'Amore PA. TGF beta is required for the formation of capillary-like structures in three-dimensional cocultures of 10T1/2 and endothelial cells. Angiogenesis 2001; 4: 11-20.
82. Ding R, Darland DC, Parmacek MS, D'Amore PA. Endothelial-mesenchymal interactions in vitro reveal molecular mechanisms of smooth muscle/pericyte differentiation. Stem Cells Dev. 2004; 13: 509-20.
83. Darland DC, Massingham LJ, Smith SR, Piek E, Saint-Geniez M, D'Amore PA. Pericyte production of cell-associated VEGF is differentiation-dependent and is associated with endothelial survival. Dev. Biol. 2003; 264: 275-88.
84. Schechner JS, Nath AK, Zheng L et al. In vivo formation of complex microvessels lined by human endothelial cells in an immunodeficient mouse. Proc. Natl. Acad. Sci. U S A 2000; 97: 9191-6.
85. Yang J, Nagavarapu U, Relloma K et al. Telomerized human microvasculature is functional in vivo. Nat. Biotechnol. 2001; 19: 219-24.
86. Koike N, Fukumura D, Gralla O, Au P, Schechner JS, Jain RK. Tissue engineering: creation of long-lasting blood vessels. Nature 2004; 428: 138-9.
87. Melero-Martin JM, De Obaldia ME, Kang SY et al. Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells. Circ. Res. 2008; 103: 194-202.
88. Traktuev DO, Merfeld-Clauss S, Li J et al. A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks. Circ. Res. 2008; 102: 77-85.
89. Au P, Tam J, Fukumura D, Jain RK. Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature. Blood 2008; 111: 4551-8.
90. Levenberg S, Rouwkema J, Macdonald M et al. Engineering vascularized skeletal muscle tissue. Nat. Biotechnol. 2005; 23: 879-84.
91. Narmoneva DA, Vukmirovic R, Davis ME, Kamm RD, Lee RT. Endothelial cells promote cardiac myocyte survival and spatial reorganization: implications for cardiac regeneration. Circulation 2004; 110: 962-8.
92. Tremblay PL, Hudon V, Berthod F, Germain L, Auger FA. Inosculation of tissue-engineered capillaries with the host's vasculature in a reconstructed skin transplanted on mice. Am. J. Transplant. 2005; 5: 1002-10.
93. Shepherd BR, Hoying JB, Williams SK. Microvascular transplantation after acute myocardial infarction. Tissue Eng. 2007; 13: 2871-9.
94. Erol OO, Spira M. New capillary bed formation with a surgically constructed arteriovenous fistula. Surg. Forum 1979; 30: 530-1.
95. Morrison WA, Dvir E, Doi K, Hurley JV, Hickey MJ, O'Brien BM. Prefabrication of thin transferable axial-pattern skin flaps: an experimental study in rabbits. Br. J. Plast. Surg. 1990; 43: 645-54.
96. Tanaka Y, Sung KC, Tsutsumi A, Ohba S, Ueda K, Morrison WA. Tissue engineering skin flaps: which vascular carrier, arteriovenous shunt loop or arteriovenous bundle, has more potential for angiogenesis and tissue generation? Plast. Reconstr. Surg. 2003; 112: 1636-44.
97. Mian R, Morrison WA, Hurley JV et al. Formation of new tissue from an arteriovenous loop in the absence of added extracellular matrix. Tissue Eng. 2000; 6: 595-603.
98. Lokmic Z, Stillaert F, Morrison WA, Thompson EW, Mitchell GM. An arteriovenous loop in a protected space generates a permanent, highly vascular, tissue-engineered construct. FASEB J. 2007; 21: 511-22.
99. Messina A, Bortolotto SK, Cassell OC, Kelly J, Abberton KM, Morrison WA. Generation of a vascularized organoid using skeletal muscle as the inductive source. FASEB J. 2005; 19: 1570-2.
100. Findlay MW, Messina A, Thompson EW, Morrison WA. Long-term persistence of tissue-engineered adipose flaps in a murine model to 1 year: an update. Plast. Reconstr. Surg. 2009; 124: 1077-84.
101. Knight KR, Uda Y, Findlay MW et al. Vascularized tissue-engineered chambers promote survival and function of transplanted islets and improve glycemic control. FASEB J. 2006; 20: 565-7.
102. Kneser U, Polykandriotis E, Ohnolz J et al. Engineering of vascularized transplantable bone tissues: induction of axial vascularization in an osteoconductive matrix using an arteriovenous loop. Tissue Eng. 2006; 12: 1721-31.
103. Kneser U, Schaefer DJ, Polykandriotis E, Horch RE. Tissue engineering of bone: the reconstructive surgeon's point of view. J. Cell. Mol. Med. 2006; 10: 7-19.
104. Cronin KJ, Messina A, Knight KR et al. New murine model of spontaneous autologous tissue engineering, combining an arteriovenous pedicle with matrix materials. Plast. Reconstr. Surg. 2004; 113: 260-9.
105. Rophael JA, Craft RO, Palmer JA et al. Angiogenic growth factor synergism in a murine tissue engineering model of angiogenesis and adipogenesis. Am. J. Pathol. 2007; 171: 2048-57.
106. Birla R, Dhawan V, Huang YC, Lytle I, Tiranathanagul K, Brown D. Force characteristics of in vivo tissue-engineered myocardial constructs using varying cell seeding densities. Artif. Organs 2008; 32: 684-91.